Zuclopenthixol tablets

Form: Oral Tablets

Strength: 10 mg, 25 mg, 40 mg

Reference Brands: Clopixol®(EU)

Category: Antipsychotropic Drugs

Zuclopenthixol tablets, used for managing schizophrenia and chronic psychoses, are not FDA-approved in the United States but are authorized in the European Union under the brand Clopixol. EU regulations require GMP compliance, pharmacovigilance systems, and bioequivalence data for registration. U.S. market entry would require a 505(b)(2) or ANDA submission with complete CMC, clinical, and labeling documentation. Regulatory focus includes psychiatric safety profiling and consistent release characteristics. For dossier-ready Zuclopenthixol tablets and to explore other available forms such as IM injections and depot formulations, visit Pharmatradz.com — your trusted platform for global pharmaceutical sourcing.